Innate Pharma SA (IPH)

Track

The most recent insider trading activity occurred on January 5, 2026, with Chief Development Officer Nicola Beltraminelli selling shares. Prior to this, on May 30, 2025, a 10% stockholder, Novo Nordisk A/S, proposed a sale of a significant number of shares. Earlier transactions in June 2022 involved multiple sell transactions by Herve Brailly, President of the Supervisory Board.

Not featured in screeners

Featured in screeners

Not featured in screeners

Stock chart

Ticker: IPH Exchange: PAR

Subscribe to get access to the transaction volume chart and in-chart transaction details

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings

Top insiders

Company data & Insiders

Subscribe to get access to the company description and key fundamental data (market cap, shares outstanding, dividend yield, % of shares held by insiders and more)

Download results Settings

Trades

Nicola Beltraminelli

Chief Development Officer

5 sales — total 31,255 EUR

Sale 5 Jan 2026

Value €1,949,067.64 | Price 495.99 | Shares 16,781

Sale 5 Jan 2026

Value €4,189,274.97 | Price 299.95 | Shares 51,865

Sale 5 Jan 2026

Value €6,894.00 | Price 1.53 | Shares 4,500

Sale 5 Jan 2026

Value €4,686.00 | Price 1.56 | Shares 3,000

Sale 5 Jan 2026

Value €4,710.00 | Price 1.57 | Shares 3,000

Novo Nordisk A/S

10% Stockholder

1 sale — total 1,972,859 USD

Proposed sale 30 May 2025

Value US$3,847,995.10 | Price 355.22 | Shares 67,855

Herve BRAILLY

President du conseil de surveillance

2 sales — total 51,783 EUR

Sale 30 Jun 2022

Value €26,266.00 | Price 2.63 | Shares 10,000

Sale 30 Jun 2022

Value €25,517.00 | Price 2.55 | Shares 10,000

Herve BRAILLY

President du conseil de surveillance

3 sales — total 76,352 EUR

Sale 23 Jun 2022

Value €25,802.00 | Price 2.58 | Shares 10,000

Sale 23 Jun 2022

Value €25,495.00 | Price 2.55 | Shares 10,000

Sale 23 Jun 2022

Value €25,055.00 | Price 2.51 | Shares 10,000

Herve BRAILLY

President du conseil de surveillance

6 sales — total 152,147 EUR

Sale 17 Jun 2022

Value €26,297.00 | Price 2.63 | Shares 10,000

Sale 17 Jun 2022

Value €26,803.00 | Price 2.68 | Shares 10,000

Sale 17 Jun 2022

Value €25,056.00 | Price 2.51 | Shares 10,000

Sale 17 Jun 2022

Value €25,559.00 | Price 2.56 | Shares 10,000

Sale 17 Jun 2022

Value €24,462.00 | Price 2.45 | Shares 10,000

Sale 17 Jun 2022

Value €23,970.00 | Price 2.40 | Shares 10,000

HERVE BRAILLY

President du conseil de surveillance

2 sales — total 49,036 EUR

Sale 15 Jun 2022

Value €24,241.00 | Price 2.42 | Shares 10,000

Sale 15 Jun 2022

Value €24,795.00 | Price 2.48 | Shares 10,000

HERVE BRAILLY

President du conseil de surveillance

1 sale — total 25,330 EUR

Sale 10 Jun 2022

Value €25,330.00 | Price 2.53 | Shares 10,000

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other

Notification date	Transaction date	B/S Transaction type	Insider and/or position	Nb. shares Price Value	Number of shares	Price	Value
2026-01-13	2026-01-05	S Sale	3.0 Nicola Beltraminelli Chief Development Officer Officer	16,781 495.99 €1,949,068	16,781	495.99	€1,949,068
2026-01-13	2026-01-05	S Sale	3.0 Nicola Beltraminelli Chief Development Officer Officer	51,865 299.95 €4,189,275	51,865	299.95	€4,189,275
2026-01-13	2026-01-05	S Sale	3.0 Nicola Beltraminelli Chief Development Officer Officer	71,629 128.27 €801,315	71,629	128.27	€801,315
2026-01-13	2026-01-05	S Sale	3.0 Nicola Beltraminelli Chief Development Officer Officer	3,000 1.56 €4,686	3,000	1.56	€4,686
2026-01-13	2026-01-05	S Sale	3.0 Nicola Beltraminelli Chief Development Officer Officer	3,000 1.57 €4,710	3,000	1.57	€4,710
2025-05-30	2025-05-30	PrS Proposed sale	Novo Nordisk A/S 10% Stockholder Large shareholder	921,897 2.14 US$1,972,859	921,897	2.14	US$1,972,859
2022-07-06	2022-06-30	S Sale	3.5 Herve BRAILLY President du conseil de surveillance Supervisory Board Member	10,000 2.63 €26,266	10,000	2.63	€26,266
2022-07-06	2022-06-30	S Sale	3.5 Herve BRAILLY President du conseil de surveillance Supervisory Board Member	10,000 2.55 €25,517	10,000	2.55	€25,517
2022-06-29	2022-06-23	S Sale	3.5 Herve BRAILLY President du conseil de surveillance Supervisory Board Member	10,000 2.58 €25,802	10,000	2.58	€25,802
2022-06-29	2022-06-23	S Sale	3.5 Herve BRAILLY President du conseil de surveillance Supervisory Board Member	10,000 2.55 €25,495	10,000	2.55	€25,495
2022-06-29	2022-06-23	S Sale	3.5 Herve BRAILLY President du conseil de surveillance Supervisory Board Member	10,000 2.51 €25,055	10,000	2.51	€25,055
2022-07-06	2022-06-17	S Sale	3.5 Herve BRAILLY President du conseil de surveillance Supervisory Board Member	10,000 2.63 €26,297	10,000	2.63	€26,297
2022-07-06	2022-06-17	S Sale	3.5 Herve BRAILLY President du conseil de surveillance Supervisory Board Member	10,000 2.68 €26,803	10,000	2.68	€26,803
2022-07-06	2022-06-17	S Sale	3.5 Herve BRAILLY President du conseil de surveillance Supervisory Board Member	10,000 2.51 €25,056	10,000	2.51	€25,056
2022-07-06	2022-06-17	S Sale	3.5 Herve BRAILLY President du conseil de surveillance Supervisory Board Member	10,000 2.56 €25,559	10,000	2.56	€25,559
2022-07-06	2022-06-17	S Sale	3.5 Herve BRAILLY President du conseil de surveillance Supervisory Board Member	10,000 2.45 €24,462	10,000	2.45	€24,462
2022-07-06	2022-06-17	S Sale	3.5 Herve BRAILLY President du conseil de surveillance Supervisory Board Member	10,000 2.40 €23,970	10,000	2.40	€23,970
2022-06-21	2022-06-15	S Sale	3.5 HERVE BRAILLY President du conseil de surveillance Supervisory Board Member	10,000 2.42 €24,241	10,000	2.42	€24,241
2022-06-21	2022-06-15	S Sale	3.5 HERVE BRAILLY President du conseil de surveillance Supervisory Board Member	10,000 2.48 €24,795	10,000	2.48	€24,795
2022-06-20	2022-06-10	S Sale	3.5 HERVE BRAILLY President du conseil de surveillance Supervisory Board Member	10,000 2.53 €25,330	10,000	2.53	€25,330